Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

Published:2014-03 Issue:3 Volume:15 Page:297-304
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Flaherty Keith T,Hennig Michael,Lee Sandra J,Ascierto Paolo A,Dummer Reinhard,Eggermont Alexander M M,Hauschild Axel,Kefford Richard,Kirkwood John M,Long Georgina V,Lorigan Paul,Mackensen Andreas,McArthur Grant,O'Day Steven,Patel Poulam M,Robert Caroline,Schadendorf Dirk

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

4. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial;Hauschild;Lancet,2012

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS);European Journal of Cancer;2024-06

2. Twenty years of network meta‐analysis: Continuing controversies and recent developments;Research Synthesis Methods;2024-01-18

3. The Reporting and Methodological Quality of Systematic Reviews Underpinning Clinical Practice Guidelines Focused on the Management of Cutaneous Melanoma: Cross-Sectional Analysis;JMIR Dermatology;2023-12-07

4. Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes;Journal of Modern Oncology;2022-07-15

5. Correlation Between Early Time-to-Event Outcomes and Overall Survival in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving Definitive Chemoradiation Therapy: Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-04-28